Psoriatic Arthritis

At the 2023 European Congress of Rheumatology, Amgen presented study results evaluating the use of Otezla for the treatment of psoriatic arthritis, according to a company press release.

Patients with anxiety or depression are less likely to exhibit healthy self-management for their rheumatoid arthritis, psoriatic arthritis or axial spondyloarthritis, according to data presented at EULAR 2023 Congress.

EULAR has removed the use of systemic glucocorticoids from its recommendations for the management of psoriatic arthritis, according to a presentation at the EULAR 2023 Congress.

Spatial transcriptomic profiling showed that lesional and distal, nonlesional areas in patients with psoriasis stratify by disease severity and not by the presence of disease, according to a study from NYU Langone Health.

UCB announced new long-term data from BE COMPLETE’s 52-week open label extension evaluating the efficacy and safety of bimekizumab in adults with active psoriatic arthritis, according to a press release.

Joint pain and decreased daily physical activity can contribute to patients with psoriatic arthritis having trouble falling or staying asleep, but the sleep issues often are overlooked and go untreated, according to researchers.

The pipeline of Janus kinase inhibitors is robust even as researchers struggle to fully understand how they work, according to a presenter at the 2023 Biologic Therapies Summit.

DESTIN, Fla. — Efficacy is just one of many factors that should be considered when choosing therapies for rheumatoid arthritis and psoriatic arthritis, according to a presenter at the 2023 Congress of Clinical Rheumatology-East.

DESTIN, Fla. — Understanding which psoriatic arthritis disease domains are most important to the patient may help guide therapeutic decision-making, according to a presenter at the 2023 Congress of Clinical Rheumatology-East.